CareLit Fachartikel

Dietary Eicosapentaenoic Acid (EPA) and Arachidic Acid as Predictors of Positive Therapy Response in Multiple Myeloma Patients

Gambihler, A.; Sester, L.; Poschet, G.; Stein-Thoeringer, C.K.; Raab, M. · Aktuelle Ernährungsmedizin · 2025 · Heft 2 · S. 1 bis 1

Dokument
349621
CareLit-ID
Jahr
2025
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Aktuelle Ernährungsmedizin
Autor:innen
Gambihler, A.; Sester, L.; Poschet, G.; Stein-Thoeringer, C.K.; Raab, M.
Ausgabe
Heft 2 / 2025
Jahrgang 19
Seiten
1 bis 1
Erschienen: 2025-05-25 13:00:00
ISSN
0341-0501

Zusammenfassung

Introduction: Multiple myeloma (MM) is a hematologic malignancy characterized by plasma cell infiltration of the bone marrow. Nutritional factors, particularly anti-inflammatory fatty acids, may influence disease progression and therapy outcomes. Objectives: Eicosapentaenoic acid (EPA) and arachidic acid are long-chain fatty acids with potential therapeutic benefits. However, their role, along with short-chain fatty acids (SCFAs), polyunsaturated fatty acids (PUFAs), and oleic acid, in predicting treatment response remains unclear. Methods: This study evaluates the association between fatty acid intake and thera…

Schlagworte

Eicosapentaensäure Arachidonsäure Multiple Myelom Therapieansprechen Patienten Ernährung Fettsäuren Eicosapentaenoic Acid Arachidonic Acid Multiple Myeloma Dietary Fats Treatment Outcome Fatty Acids Aktuelle Ernährungsmedizin